TY - JOUR
T1 - Pneumococcal conjugate vaccines
AU - Peeters, Carla C.A.M.
AU - Tenbergen-Meekes, Anne Marie
AU - Haagmans, Bart
AU - Evenberg, Dolf
AU - Poolman, Jan T.
AU - Zegers, Ben J.M.
AU - Rijkers, Ger T.
N1 - Copyright © 1991 Published by Elsevier B.V
PY - 1991/10
Y1 - 1991/10
N2 - We have prepared conjugates of pneumococcal type 4 polysaccharides (PS4) or oligosaccharides to tetanus toxoid using the carbodiimide method. The use of a spacer, 6-aminohexanoic acid, resulted in higher incorporation of carrier protein. Conjugates contained up to 10% free polysaccharide, but no free protein. In general, polysaccharide conjugates induced higher anti-PS4 IgG antibody titers than oligosaccharide conjugates. Conjugates with the highest amount of incorporated protein were the most immunogenic. The response to conjugated PS4 does show characteristics of a T cell-dependent antibody response, in terms of both isotype distribution and induction of immunological memory. Repeated immunization with high doses of PS4TT conjugate resulted in a virtually negative anti-PS4 IgG response, suggestive of the induction of high dose tolerance.
AB - We have prepared conjugates of pneumococcal type 4 polysaccharides (PS4) or oligosaccharides to tetanus toxoid using the carbodiimide method. The use of a spacer, 6-aminohexanoic acid, resulted in higher incorporation of carrier protein. Conjugates contained up to 10% free polysaccharide, but no free protein. In general, polysaccharide conjugates induced higher anti-PS4 IgG antibody titers than oligosaccharide conjugates. Conjugates with the highest amount of incorporated protein were the most immunogenic. The response to conjugated PS4 does show characteristics of a T cell-dependent antibody response, in terms of both isotype distribution and induction of immunological memory. Repeated immunization with high doses of PS4TT conjugate resulted in a virtually negative anti-PS4 IgG response, suggestive of the induction of high dose tolerance.
UR - http://www.scopus.com/inward/record.url?scp=0025945838&partnerID=8YFLogxK
U2 - 10.1016/0165-2478(91)90036-A
DO - 10.1016/0165-2478(91)90036-A
M3 - Article
C2 - 1757114
AN - SCOPUS:0025945838
SN - 0165-2478
VL - 30
SP - 267
EP - 274
JO - Immunology Letters
JF - Immunology Letters
IS - 2
ER -